AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
204.72
+4.25 (2.12%)
Apr 17, 2026, 11:45 AM EDT - Market open

AstraZeneca Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12,4028,6916,8992,501-265
Depreciation & Amortization
5,7336,6885,3875,4806,530
Stock-Based Compensation
---619615
Other Adjustments
422125125-307-580
Change in Receivables
-1,728-1,624-1,425-1,349-961
Changes in Inventories
-755-131-6693,9411,577
Changes in Accounts Payable
1,3468622,3941,1651,405
Changes in Income Taxes Payable
-2,845-2,750-2,366-1,623-1,743
Operating Cash Flow
14,57511,86110,3459,8085,963
Operating Cash Flow Growth
22.88%14.65%5.47%64.48%24.25%
Capital Expenditures
-2,810-1,924-1,361-1,091-1,091
Sale of Property, Plant & Equipment
135513228213
Purchases of Intangible Assets
-3,095-2,662-2,417-1,480-1,109
Proceeds from Sale of Intangible Assets
136123291447587
Purchases of Investments
-239-254-216-71-276
Proceeds from Sale of Investments
-913242785
Payments for Business Acquisitions
-1,230-3,779-1,015-820-9,906
Other Investing Activities
417370490-269-61
Investing Cash Flow
-6,808-7,980-4,064-2,960-11,058
Short-Term Debt Issued
364-3116174-552
Net Short-Term Debt Issued (Repaid)
364-3116174-552
Long-Term Debt Issued
156,4923,816-25,858
Long-Term Debt Repaid
-2,029-4,652-4,942-1,271-9,518
Net Long-Term Debt Issued (Repaid)
-2,0141,840-1,126-1,27116,340
Issuance of Common Stock
4038332929
Repurchase of Common Stock
-521-81---
Net Common Stock Issued (Repurchased)
-481-43332929
Common Dividends Paid
-4,971-4,629-4,481-4,364-3,856
Other Financing Activities
-442-1,133-1,154-1,291-418
Financing Cash Flow
-7,544-3,996-6,567-6,8233,649
Effect of Exchange Rate Changes on Cash and Cash Equivalents
46-93-60-80-62
Net Cash Flow
223-115-28625-1,446
Free Cash Flow
11,7659,9378,9848,7174,872
Free Cash Flow Growth
18.40%10.61%3.06%78.92%26.94%
FCF Margin
20.03%18.38%19.61%19.65%13.02%
Free Cash Flow Per Share
3.773.182.882.791.71
Levered Free Cash Flow
9,24411,5898,3759,96322,578
Unlevered Free Cash Flow
12,00910,84910,46412,8196,220
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q